Irish biotech Aerska raises $21 million to develop RNA-based therapies for neurologica

Aerska, an Irish-based biotech company, pioneering groundbreaking therapies for diseases of the brain, has announced it has raised $21m in seed funding. Founded by Jack O’Meara, an Irish serial biotech entrepreneur, alongside David Hardwicke and leading RNA scientist Stu Milstein, they are joined by a team of seasoned drug developers based out of D...

• Published date: 02-10-2025 12:00 PM